A

Researcher Profile

Aaron Prendergast

🏛 Barts ECMC, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

0000-0002-9668-6689

3

Publications

911

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article Journal of Clinical Oncology May 10, 2023

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

Cristina Suarez · James M.G. Larkin · Poulam Patel · Begoña P. Valderrama +12 more

10.1200/jco.22.01414 47 citations

Journal Article Journal of Clinical Oncology Feb 10, 2020

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid · Jacinta Abraham · Stephen Chan · Duncan Wheatley +25 more

10.1200/jco.19.00368 331 citations

Journal Article Nature Medicine Nov 01, 2019

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles · Mark Kockx · Alejo Rodriguez-Vida · Ignacio Duran +21 more

10.1038/s41591-019-0628-7 533 citations

Publication Timeline

2023

1

2020

1

2019

1

Frequent Co-Authors

Bernadett Szabados

Cristina Suarez

Alejo Rodriguez-Vida

Gwenaëlle Gravis

Richard D. Baird